Combining Traditional Statistical Methods with Explainable Machine Learning for Assessing Recurrence Risk of Atrial Fibrillation Following Pulsed Field Ablation

Overview

This study explores the use of explainable machine learning to predict recurrence risk of atrial fibrillation (AF) after pulsed field ablation (PFA). It highlights the potential of NT-proBNP as a biomarker for assessing recurrence risk in a contemporary cohort of patients with paroxysmal AF.

Background

Atrial fibrillation is the most common sustained cardiac arrhythmia, and catheter ablation is a key treatment for symptomatic paroxysmal AF. Despite advancements in ablation technologies like pulsed field ablation, post-procedural recurrence remains a significant challenge, leading to increased healthcare costs and patient burden. There is a need for improved predictive tools tailored to the unique characteristics of patients undergoing PFA.

Data Highlights

This study is exploratory and does not present numerical data in a tabular format.

Key Findings

• NT-proBNP may serve as a sensitive biomarker for predicting AF recurrence post-PFA.
• Traditional risk scores may be inadequate in the contemporary PFA population due to a ceiling effect.
• Explainable machine learning techniques can identify complex interactions and risk thresholds relevant to AF recurrence.
• The study emphasizes the necessity for technology-specific predictive tools for PFA.
• Initial findings suggest a potential biomarker-substrate-field interaction that warrants further investigation.

Clinical Implications

Clinicians should consider the use of NT-proBNP as a potential biomarker for assessing recurrence risk in patients undergoing PFA for paroxysmal AF. The integration of explainable machine learning may enhance risk stratification and inform personalized treatment strategies.

Conclusion

This study underscores the importance of developing tailored predictive models for AF recurrence following PFA, utilizing both traditional and machine learning approaches to improve patient outcomes.

References

1. npj Digital Medicine, 2026 -- A deep learning model integrating structured data and clinical text for predicting atrial fibrillation recurrence
2. Clinical Research in Cardiology, 2020 -- Post-Ablation Sinus Heart Rate and Long-Term Recurrence Risks in Patients with Atrial Fibrillation
3. Clinical Research in Cardiology, 2024 -- Link Between Atrial Mechanical Dispersion and Recurrence of Atrial Fibrillation After Catheter Ablation: Findings from the ASTRA-AF Pilot Study
4. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) | European Heart Journal | Oxford Academic
5. Clinical Research in Cardiology — Factors Influencing Fibrotic Atrial Cardiomyopathy in Atrial Fibrillation: Insights from a Multicenter Observational Study by the RETAC Group
6. Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation - PubMed
7. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) | European Heart Journal | Oxford Academic
8. Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial | Nature Medicine